Clinical Trial Update: The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

The document reports on a Phase 1/2 clinical trial evaluating Macugen (pegaptanib sodium) in patients with chronic, post-operative cystoid macular edema, which …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cystoid Macular Edema | Phase 1, Phase 2 | Status: TERMINATED